Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Agolory, Simon"" wg kryterium: Autor


Tytuł:
Implementation of non-pharmaceutical interventions by New York City public schools to prevent 2009 influenza A.
Autorzy:
Agolory SG; Epidemic Intelligence Services, Centers for Disease Control and Prevention, Atlanta, GA, USA. />Barbot O
Averhoff F
Weiss D
Wilson E
Egger J
Miller J
Ogbuanu I
Walton S
Kahn E
Pokaż więcej
Źródło:
PloS one [PLoS One] 2013; Vol. 8 (1), pp. e50916. Date of Electronic Publication: 2013 Jan 15.
Typ publikacji:
Journal Article; Research Support, U.S. Gov't, P.H.S.
MeSH Terms:
Health Plan Implementation/*statistics & numerical data
Influenza, Human/*prevention & control
Influenza, Human/*therapy
Schools/*statistics & numerical data
Adolescent ; Communication ; Data Collection/statistics & numerical data ; Health Education/statistics & numerical data ; Humans ; Hygiene ; Influenza A Virus, H1N1 Subtype/physiology ; Influenza, Human/epidemiology ; Influenza, Human/virology ; Internet ; New York City/epidemiology ; Research Report ; Sanitation/statistics & numerical data
Czasopismo naukowe
Tytuł:
Retention and risk factors for attrition among adults in antiretroviral treatment programmes in Tanzania, Uganda and Zambia.
Autorzy:
Koole, Olivier
Tsui, Sharon
Wabwire ‐ Mangen, Fred
Kwesigabo, Gideon
Menten, Joris
Mulenga, Modest
Auld, Andrew
Agolory, Simon
Mukadi, Ya Diul
Colebunders, Robert
Bangsberg, David R.
Praag, Eric
Torpey, Kwasi
Williams, Seymour
Kaplan, Jonathan
Zee, Aaron
Denison, Julie
Pokaż więcej
Źródło:
Tropical Medicine & International Health. Dec2014, Vol. 19 Issue 12, p1397-1410. 14p. 6 Charts, 2 Graphs.
Czasopismo naukowe
Tytuł:
Reasons for Missing Antiretroviral Therapy: Results from a Multi-Country Study in Tanzania, Uganda, and Zambia.
Autorzy:
Koole O; London School of Hygiene and Tropical Medicine, Department of Clinical Research, London, United Kingdom.; Institute of Tropical Medicine, Clinical Sciences Department, Antwerp, Belgium.
Denison JA; FHI 360, Social and Behavioral Health Sciences, Durham, North Carolina, United States of America.; Johns Hopkins Bloomberg School of Public Health, Department of International Health, Baltimore, Maryland, United States of America.
Menten J; Institute of Tropical Medicine, Clinical Sciences Department, Antwerp, Belgium.
Tsui S; FHI 360, Social and Behavioral Health Sciences, Durham, North Carolina, United States of America.; Johns Hopkins Bloomberg School of Public Health, Department of International Health, Baltimore, Maryland, United States of America.
Wabwire-Mangen F; Infectious Diseases Institute, Makerere University College of Health Sciences, Kampala, Uganda.
Kwesigabo G; Muhimbili University of Health and Allied Sciences, Dar es Salaam, United Republic of Tanzania.
Mulenga M; Tropical Diseases Research Centre, Ndola, Zambia.
Auld A; Division of Global HIV/AIDS, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.
Agolory S; Division of Global HIV/AIDS, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.
Mukadi YD; FHI 360, Social and Behavioral Health Sciences, Durham, North Carolina, United States of America.
van Praag E; FHI 360, Social and Behavioral Health Sciences, Durham, North Carolina, United States of America.
Torpey K; FHI 360, Social and Behavioral Health Sciences, Durham, North Carolina, United States of America.
Williams S; Division of Global HIV/AIDS, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.
Kaplan J; Division of Global HIV/AIDS, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.
Zee A; Division of Global HIV/AIDS, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.
Bangsberg DR; Massachusetts General Hospital, Boston, Massachusetts, United States of America.; Harvard Medical School, Boston, Massachusetts, United States of America.
Colebunders R; Institute of Tropical Medicine, Clinical Sciences Department, Antwerp, Belgium.; Epidemiology and Social Medicine, University of Antwerp, Antwerp, Belgium.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2016 Jan 20; Vol. 11 (1), pp. e0147309. Date of Electronic Publication: 2016 Jan 20 (Print Publication: 2016).
Typ publikacji:
Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
MeSH Terms:
Anti-Retroviral Agents/*therapeutic use
HIV/*pathogenicity
HIV Infections/*drug therapy
Medication Adherence/*statistics & numerical data
Patient Compliance/*statistics & numerical data
Adult ; Cross-Sectional Studies ; Female ; HIV Infections/psychology ; HIV Infections/virology ; Humans ; Male ; Middle Aged ; Tanzania ; Uganda ; Zambia
Czasopismo naukowe
Tytuł:
Enrollment in HIV Care Two Years after HIV Diagnosis in the Kingdom of Swaziland: An Evaluation of a National Program of New Linkage Procedures.
Autorzy:
MacKellar DA; Division of Global HIV/AIDS, National Center for Global Health, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.
Williams D; Division of Global HIV/AIDS, National Center for Global Health, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.
Storer N; ICAP at Columbia University, Mbabane, Swaziland.
Okello V; Swaziland National AIDS Programme, Swaziland Ministry of Health, Mbabane, Swaziland.
Azih C; Swaziland National AIDS Programme, Swaziland Ministry of Health, Mbabane, Swaziland.
Drummond J; Division of Global HIV/AIDS, National Center for Global Health, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.
Nuwagaba-Biribonwoha H; ICAP at Columbia University, Mbabane, Swaziland.; ICAP at Columbia University, New York, New York, United States of America.
Preko P; CTS Global assigned to Centers for Disease Control and Prevention Country Office, Mbabane, Swaziland.
Morgan RL; McMaster University, Hamilton, Ontario, Canada.
Dlamini M; Population Services International Country Program, Mbabane, Swaziland.
Byrd J; ICF International, Atlanta, Georgia, United States of America.
Agolory S; Division of Global HIV/AIDS, National Center for Global Health, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.
Baughman AL; Division of Global HIV/AIDS, National Center for Global Health, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.
McNairy ML; ICAP at Columbia University, New York, New York, United States of America.
Sahabo R; ICAP at Columbia University, Mbabane, Swaziland.
Ehrenkranz P; Bill & Melinda Gates Foundation, Seattle, Washington, United States of America.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2016 Feb 24; Vol. 11 (2), pp. e0150086. Date of Electronic Publication: 2016 Feb 24 (Print Publication: 2016).
Typ publikacji:
Journal Article; Research Support, U.S. Gov't, P.H.S.
MeSH Terms:
HIV-1*
National Health Programs*
HIV Infections/*mortality
HIV Infections/*therapy
Adult ; Eswatini/epidemiology ; Female ; Humans ; Male
Czasopismo naukowe
Tytuł:
Outcomes of Nigeria's HIV/AIDS Treatment Program for Patients Initiated on Antiretroviral Treatment between 2004-2012.
Autorzy:
Dalhatu I; Division of Global HIV/AIDS, Center for Global Health, U.S. Centers for Disease Control & Prevention, Abuja, Nigeria.
Onotu D; Division of Global HIV/AIDS, Center for Global Health, U.S. Centers for Disease Control & Prevention, Abuja, Nigeria.
Odafe S; Division of Global HIV/AIDS, Center for Global Health, U.S. Centers for Disease Control & Prevention, Abuja, Nigeria.
Abiri O; School of Biomedical Informatics, University of Texas, Houston, Texas, United States of America.
Debem H; Division of Global HIV/AIDS, Center for Global Health, U.S. Centers for Disease Control & Prevention, Abuja, Nigeria.
Agolory S; Division of Global HIV/AIDS, Center for Global Health, U.S. Centers for Disease Control & Prevention, Atlanta, Georgia, United States of America.
Shiraishi RW; Division of Global HIV/AIDS, Center for Global Health, U.S. Centers for Disease Control & Prevention, Atlanta, Georgia, United States of America.
Auld AF; Division of Global HIV/AIDS, Center for Global Health, U.S. Centers for Disease Control & Prevention, Atlanta, Georgia, United States of America.
Swaminathan M; Division of Global HIV/AIDS, Center for Global Health, U.S. Centers for Disease Control & Prevention, Atlanta, Georgia, United States of America.
Dokubo K; School of Biomedical Informatics, University of Texas, Houston, Texas, United States of America.
Ngige E; National AIDS & STIs Control Program, Federal Ministry of Health, Abuja, Nigeria.
Asadu C; National AIDS & STIs Control Program, Federal Ministry of Health, Abuja, Nigeria.
Abatta E; National AIDS & STIs Control Program, Federal Ministry of Health, Abuja, Nigeria.
Ellerbrock TV; Division of Global HIV/AIDS, Center for Global Health, U.S. Centers for Disease Control & Prevention, Atlanta, Georgia, United States of America.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2016 Nov 09; Vol. 11 (11), pp. e0165528. Date of Electronic Publication: 2016 Nov 09 (Print Publication: 2016).
Typ publikacji:
Journal Article
MeSH Terms:
Anti-HIV Agents/*therapeutic use
CD4-Positive T-Lymphocytes/*drug effects
HIV Infections/*drug therapy
Adolescent ; Adult ; Ambulatory Care Facilities/statistics & numerical data ; Antiretroviral Therapy, Highly Active ; CD4 Lymphocyte Count ; CD4-Positive T-Lymphocytes/immunology ; CD4-Positive T-Lymphocytes/virology ; Female ; HIV Infections/epidemiology ; HIV Infections/immunology ; HIV Infections/mortality ; Humans ; Lost to Follow-Up ; Male ; Middle Aged ; Nigeria/epidemiology ; Retrospective Studies ; Social Class ; Survival Analysis ; Treatment Outcome
Czasopismo naukowe
Tytuł:
Correction: Outcomes of Nigeria's HIV/AIDS Treatment Program for Patients Initiated on Antiretroviral Treatment between 2004-2012.
Autorzy:
Dalhatu I
Onotu D
Odafe S
Abiri O
Debem H
Agolory S
Shiraishi RW
Auld AF
Swaminathan M
Dokubo K
Ngige E
Asadu C
Abatta E
Ellerbrock TV
Pokaż więcej
Źródło:
PloS one [PLoS One] 2017 Jan 23; Vol. 12 (1), pp. e0170912. Date of Electronic Publication: 2017 Jan 23 (Print Publication: 2017).
Typ publikacji:
Published Erratum
Tytuł:
Incidence and predictors of tuberculosis among HIV-infected adults after initiation of antiretroviral therapy in Nigeria, 2004-2012.
Autorzy:
Pathmanathan I; Division of Global HIV and TB, U.S. Centers for Disease Control & Prevention, Atlanta, GA, United States of America.; Epidemic Intelligence Service, U.S. Centers for Disease Control & Prevention, Atlanta, GA, United States of America.
Dokubo EK; Division of Global HIV and TB, U.S. Centers for Disease Control & Prevention, Atlanta, GA, United States of America.
Shiraishi RW; Division of Global HIV and TB, U.S. Centers for Disease Control & Prevention, Atlanta, GA, United States of America.
Agolory SG; Division of Global HIV and TB, U.S. Centers for Disease Control & Prevention, Atlanta, GA, United States of America.
Auld AF; Division of Global HIV and TB, U.S. Centers for Disease Control & Prevention, Atlanta, GA, United States of America.
Onotu D; Division of Global HIV and TB, U.S. Centers for Disease Control & Prevention, Abuja, Nigeria.
Odafe S; Division of Global HIV and TB, U.S. Centers for Disease Control & Prevention, Abuja, Nigeria.
Dalhatu I; Division of Global HIV and TB, U.S. Centers for Disease Control & Prevention, Abuja, Nigeria.
Abiri O; Department of Nursing, University of South Alabama, Mobile, AL, United States of America.
Debem HC; Division of Global HIV and TB, U.S. Centers for Disease Control & Prevention, Abuja, Nigeria.
Bashorun A; HIV/AIDS Division, Federal Ministry of Health, Abuja, Nigeria.
Ellerbrock T; Division of Global HIV and TB, U.S. Centers for Disease Control & Prevention, Atlanta, GA, United States of America.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2017 Mar 10; Vol. 12 (3), pp. e0173309. Date of Electronic Publication: 2017 Mar 10 (Print Publication: 2017).
Typ publikacji:
Journal Article
MeSH Terms:
Anti-Retroviral Agents/*therapeutic use
HIV Infections/*drug therapy
Tuberculosis/*diagnosis
Adolescent ; Adult ; CD4 Lymphocyte Count ; Female ; HIV Infections/mortality ; HIV Infections/pathology ; Humans ; Incidence ; Kaplan-Meier Estimate ; Male ; Middle Aged ; Nigeria/epidemiology ; Proportional Hazards Models ; Retrospective Studies ; Tuberculosis/epidemiology ; Young Adult
Czasopismo naukowe
Tytuł:
Trends in Prevalence of Advanced HIV Disease at Antiretroviral Therapy Enrollment - 10 Countries, 2004-2015.
Autorzy:
Auld AF
Shiraishi RW
Oboho I
Ross C
Bateganya M
Pelletier V
Dee J
Francois K
Duval N
Antoine M
Delcher C
Desforges G
Griswold M
Domercant JW
Joseph N
Deyde V
Desir Y
Van Onacker JD
Robin E
Chun H
Zulu I
Pathmanathan I
Dokubo EK
Lloyd S
Pati R
Kaplan J
Raizes E
Spira T
Mitruka K
Couto A
Gudo ES
Mbofana F
Briggs M
Alfredo C
Xavier C
Vergara A
Hamunime N
Agolory S
Mutandi G
Shoopala NN
Sawadogo S
Baughman AL
Bashorun A
Dalhatu I
Swaminathan M
Onotu D
Odafe S
Abiri OO
Debem HH
Tomlinson H
Okello V
Preko P
Ao T
Ryan C
Bicego G
Ehrenkranz P
Kamiru H
Nuwagaba-Biribonwoha H
Kwesigabo G
Ramadhani AA
Ng'wangu K
Swai P
Mfaume M
Gongo R
Carpenter D
Mastro TD
Hamilton C
Denison J
Wabwire-Mangen F
Koole O
Torpey K
Williams SG
Colebunders R
Kalamya JN
Namale A
Adler MR
Mugisa B
Gupta S
Tsui S
van Praag E
Nguyen DB
Lyss S
Le Y
Abdul-Quader AS
Do NT
Mulenga M
Hachizovu S
Mugurungi O
Barr BAT
Gonese E
Mutasa-Apollo T
Balachandra S
Behel S
Bingham T
Mackellar D
Lowrance D
Ellerbrock TV
Pokaż więcej
Źródło:
MMWR. Morbidity and mortality weekly report [MMWR Morb Mortal Wkly Rep] 2017 Jun 02; Vol. 66 (21), pp. 558-563. Date of Electronic Publication: 2017 Jun 02.
Typ publikacji:
Journal Article
MeSH Terms:
Anti-Retroviral Agents/*therapeutic use
HIV Infections/*drug therapy
HIV Infections/*epidemiology
Africa/epidemiology ; CD4 Lymphocyte Count/statistics & numerical data ; HIV Infections/immunology ; Haiti/epidemiology ; Humans ; Prevalence ; Vietnam/epidemiology
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies